about
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseaseImpact of Extracorporeal Membrane Oxygenation on Acute Fulminant Myocarditis-related Hemodynamic Compromise Arrhythmia in Children.Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based studyEthnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. ChildrenEarly and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats.Brain Stem Hemorrhage in a 2-Year-10-Month-Old Child with Renovascular Hypertension Related to Fibromuscular Dysplasia.Comparison of the Functional microRNA Expression in Immune Cell Subsets of Neonates and Adults.Diagnostic Value of Bronchoalveolar Lavage in Children with Nonresponding Community-Acquired Pneumonia.Rebound Thymic Hyperplasia after Chemotherapy in Children with Lymphoma.Application of desaturation index in post-surgery follow-up in children with obstructive sleep apnea syndrome.Efficacy and Safety of Transthoracic Echocardiography Alone in Transcatheter Closure of Secundum-Type Atrial Septal Defects in Adults.Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents.Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease.The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A).Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays.Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children.Age-Dependent Effects of Prenatal Dexamethasone Exposure on Immune Responses in Male Rats.Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.Hepatic Pathology in Patients after Fontan Operation: A CT imaging studyCardiac Tumor Presenting as Acute Right Hemiparesis in a 13-Year-Old BoyAn Acoustic Tracking Approach for Medical Ultrasound Image SimulatorAdenovirus infection and subsequent risk of Kawasaki disease: A population-based cohort studyNovel mutations of IRF6 gene in Taiwanese Van der Woude syndrome patients
P50
Q28396984-1AD93DE8-5411-4C1D-99ED-ABAB0E28CDEFQ33167130-8A8078D3-50D5-4DD1-B797-B06AC63B1E4FQ35000809-766C0834-523C-4851-B409-C2D8A626B1E6Q36513183-EFDB2947-1B94-43E2-AB8F-CD231CB28C71Q36639916-6C2F9678-FB8F-4AF5-9BF8-05A983C4C914Q36721792-7222B839-3B25-4641-A83E-0DFB48835B28Q37512191-2BD75E5D-735F-4C5E-8A47-15B3ACC57091Q38870563-5CD0A478-B9B1-4D8F-BCE4-909A9953A55AQ38882687-22BF30A0-BAB0-4D25-A40C-7635D538553BQ39479558-8D3BB4D0-3E4E-42CB-A873-5CBF1A9F9E29Q40369078-298CC65F-844F-4211-962B-2578C0CDFECBQ40476130-C882636B-4B09-4513-B3E8-A3A10D4DB022Q41613086-CAEAB351-09AE-4125-9068-7352BE129E12Q42315522-C547F98D-448F-4821-A057-499DEE7A9E70Q42678825-F36A1B70-E6EB-46CC-A204-3FEDE19034A7Q42759549-4FFAA970-D7D6-41C2-97EF-F8A4C4301440Q43667851-12DD6C05-BA82-4867-B5AF-8376E5FB7144Q47287596-B9ADF370-A229-49BD-AEA8-890688D3CA9AQ47656151-0B79C31D-0EA2-4DD5-8236-B165BA4EF656Q47938003-BF8D9BB6-0416-4C51-845A-891B7300866CQ48080783-8A4981FB-8D86-4086-BAC9-90EF8E3AADEBQ50923280-ED765B3C-C326-4E61-9721-A1747742691DQ55446513-2855F20B-E81B-426E-834E-D0AEB068EFD1Q90092238-FE38B057-D28B-4E95-AEDC-A9AD0B35B16DQ90576595-2A6D2368-83E0-4CC5-B74A-568070E1E93AQ92987320-AB2D87D5-471F-4584-A7DB-92958C3C074DQ92994998-90D08E79-0666-44BA-B2DD-C092DC75CDACQ93079860-D23CCDBD-4338-4073-831B-2BDE261A58EB
P50
description
researcher
@en
wetenschapper
@nl
name
Kai-Sheng Hsieh
@en
Kai-Sheng Hsieh
@nl
type
label
Kai-Sheng Hsieh
@en
Kai-Sheng Hsieh
@nl
prefLabel
Kai-Sheng Hsieh
@en
Kai-Sheng Hsieh
@nl
P31
P496
0000-0002-0294-9872